Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress
Go back to Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress| (NASDAQ: LTRN) | Delayed: 1.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.50 | 52 Week High | $ | |||
| Open | $1.50 | 52 Week Low | $ | |||
| Day High | $1.50 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $ | |||
| Volume | 1,080 | |||||
